Absci Corporation (ABSI)
Designs antibody drugs to treat inflammatory bowel disease, hair loss, and cancer
$7.13-0.06%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+145.9%
The outlook
ABSI is trading at $7.13 with strong analyst backing—nine analysts average a "Strong Buy" rating. The stock sits midway in its 52-week range with mixed momentum relative to moving averages. The average analyst price target implies roughly 93% upside from current levels.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range50% of the way from its 52-week low to high
Price targetAvg target +93% vs current price
Analyst price target
~12-month · 9 analysts$13.78average target+93.2% vs now
Now $7.13
Low $10.00High $17.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.21B
52-wk high
$12.06
52-wk low
$2.24
50-day avg
$7.93
200-day avg
$4.57
Trailing P/E
—